Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
- Peter Lynch
What is insider trading>>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. )*
LIVONGO HEALTH, INC.
(Name of Issuer)
Common Stock, $0.001 par value per share
(Title of Class of Securities)
539183103
(CUSIP Number)
December 31, 2019
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ Rule 13d-1(b)
☐ Rule 13d-1(c)
☒ Rule 13d-1(d)
* | The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. |
The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No. 539183103 | Page 2 |
1 | NAME OF REPORTING PERSON:
7Wire Ventures LLCSeries EosHealth | |||||
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):
46-3424640 | ||||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): (a) ☐ (b) ☐
| |||||
3 | SEC USE ONLY:
| |||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION:
Illinois |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5 | SOLE VOTING POWER
0 | ||||
6 | SHARED VOTING POWER
3,373,987 | |||||
7 | SOLE DISPOSITIVE POWER
0 | |||||
8 | SHARED DISPOSITIVE POWER
3,373,987 |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
3,373,987 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):
☐ | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):
3.6%(1) | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
OO |
(1) | Based on approximately 94,482,000 shares of the Issuers common stock outstanding as of October 31, 2019, as reported in the Issuers Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2019, filed with the Securities and Exchange Commission on November 8, 2019. |
CUSIP No. 539183103 | Page 3 |
1 | NAME OF REPORTING PERSON:
7Wire Ventures LLCSeries Livongo C | |||||
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):
81-2035982 | ||||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): (a) ☐ (b) ☐
| |||||
3 | SEC USE ONLY:
| |||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION:
Illinois |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5 | SOLE VOTING POWER
0 | ||||
6 | SHARED VOTING POWER
285,131 | |||||
7 | SOLE DISPOSITIVE POWER
0 | |||||
8 | SHARED DISPOSITIVE POWER
285,131 |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
285,131 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):
☐ | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):
0.3%(1) | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
OO |
(1) | Based on approximately 94,482,000 shares of the Issuers common stock outstanding as of October 31, 2019, as reported in the Issuers Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2019, filed with the Securities and Exchange Commission on November 8, 2019. |
CUSIP No. 539183103 | Page 4 |
1 | NAME OF REPORTING PERSON:
7Wire Ventures LLCSeries Livongo D | |||||
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):
81-5458952 | ||||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): (a) ☐ (b) ☐
| |||||
3 | SEC USE ONLY:
| |||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION:
Illinois |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5 | SOLE VOTING POWER
0 | ||||
6 | SHARED VOTING POWER
361,718 | |||||
7 | SOLE DISPOSITIVE POWER
0 | |||||
8 | SHARED DISPOSITIVE POWER
361,718 |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
361,718 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):
☐ | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):
0.4%(1) | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
OO |
(1) | Based on approximately 94,482,000 shares of the Issuers common stock outstanding as of October 31, 2019, as reported in the Issuers Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2019, filed with the Securities and Exchange Commission on November 8, 2019. |
CUSIP No. 539183103 | Page 5 |
1 | NAME OF REPORTING PERSON:
7Wire Ventures LLCSeries Livongo E | |||||
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):
82-5090469 | ||||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): (a) ☐ (b) ☐
| |||||
3 | SEC USE ONLY:
| |||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION:
Illinois |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5 | SOLE VOTING POWER
0 | ||||
6 | SHARED VOTING POWER
400,528 | |||||
7 | SOLE DISPOSITIVE POWER
0 | |||||
8 | SHARED DISPOSITIVE POWER
400,528 |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
400,528 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):
☐ | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):
0.4%(1) | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
OO |
(1) | Based on approximately 94,482,000 shares of the Issuers common stock outstanding as of October 31, 2019, as reported in the Issuers Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2019, filed with the Securities and Exchange Commission on November 8, 2019. |
CUSIP No. 539183103 | Page 6 |
1 | NAME OF REPORTING PERSON:
7Wire Ventures Fund, L.P. | |||||
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):
38-3990799 | ||||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): (a) ☐ (b) ☐
| |||||
3 | SEC USE ONLY:
| |||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION:
Delaware |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5 | SOLE VOTING POWER
0 | ||||
6 | SHARED VOTING POWER
1,159,901 | |||||
7 | SOLE DISPOSITIVE POWER
0 | |||||
8 | SHARED DISPOSITIVE POWER
1,159,901 |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
1,159,901 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):
☐ | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):
1.2%(1) | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
PN |
(1) | Based on approximately 94,482,000 shares of the Issuers common stock outstanding as of October 31, 2019, as reported in the Issuers Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2019, filed with the Securities and Exchange Commission on November 8, 2019. |
CUSIP No. 539183103 | Page 7 |
1 | NAME OF REPORTING PERSON:
7Wire Management, LLC | |||||
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):
81-1341302 | ||||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): (a) ☐ (b) ☐
| |||||
3 | SEC USE ONLY:
xA0; | |||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION:
Delaware |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5 | SOLE VOTING POWER
1,159,901(1) | ||||
6 | SHARED VOTING POWER
0 | |||||
7 | SOLE DISPOSITIVE POWER
1,159,901(1) | |||||
8 | SHARED DISPOSITIVE POWER
0 |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
1,159,901(1) | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):
☐ | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):
1.2%(2) | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
OO |
(1) | The shares are held of record by 7Wire Ventures Fund, L.P. for which 7Wire Management, LLC, or 7Wire Management, serves as the Manager. |
(2) | Based on approximately 94,482,000 shares of the Issuers common stock outstanding as of October 31, 2019, as reported in the Issuers Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2019, filed with the Securities and Exchange Commission on November 8, 2019. |
CUSIP No. 539183103 | Page 8 |
1 | NAME OF REPORTING PERSON:
Glen Tullman | |||||
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):
| ||||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): (a) ☐ (b) ☐
| |||||
3 | SEC USE ONLY:
| |||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION:
United States |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5 | SOLE VOTING POWER
4,356,399(1) | ||||
6 | SHARED VOTING POWER
5,581,265(1) | |||||
7 | SOLE DISPOSITIVE POWER
4,356,399(1) | |||||
8 | SHARED DISPOSITIVE POWER
5,581,265(1) |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
9,937,664 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):
☐ | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):
10.1%(2) | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
IN |
(1) | Consists of (i) 799,163 shares held of record by Mr. Tullman; (ii) 3,557,236 options exercisable within 60 days of December 31, 2019; (iii) 3,373,987 shares held of record by 7Wire Ventures LLC-Series EosHealth; (iv) 285,131 shares held of record by 7Wire Ventures LLCSeries Livongo C; (v) 361,718 shares held of record by 7Wire Ventures LLCSeries Livongo D; (vi) 400,528 shares held of record by 7Wire Ventures LLCSeries Livongo E, collectively, the 7Wire Series; and (vii) 1,159,901 shares held of record by 7Wire Ventures Fund, L.P. for which 7Wire Management, LLC, or 7Wire Management, serves as the Manager. As a Manager of 7Wire Series and 7Wire Management, Mr. Tullman shares voting and dispositive power with respect to the shares held of record by 7Wire Series and 7Wire LP. |
(2) | Based on approximately 94,482,000 shares of the Issuers common stock outstanding as of October 31, 2019, as reported in the Issuers Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2019, filed with the Securities and Exchange Commission on November 8, 2019. |
CUSIP No. 539183103 | Page 9 |
1 | NAME OF REPORTING PERSON:
Lee Shapiro | |||||
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):
| ||||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): (a) ☐ (b) ☐
| |||||
3 | SEC USE ONLY:
| |||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION:
United States |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5 | SOLE VOTING POWER
1,127,202(1) | ||||
6 | SHARED VOTING POWER
5,581,265(1) | |||||
7 | SOLE DISPOSITIVE POWER
1,127,202(1) | |||||
8 | SHARED DISPOSITIVE POWER
5,581,265(1) |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
6,708,467(1) | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):
☐ | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):
7.1%(2) | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
IN |
(1) | Consists of (i) 841,314 shares held of record by Mr. Shapiro; (ii) 285,888 shares issuable upon vesting of restricted stock units within 60 days of December 31, 2019; (iii) 3,373,987 shares held of record by 7Wire Ventures LLC-Series EosHealth; (iv) 285,131 shares held of record by 7Wire Ventures LLCSeries Livongo C; (v) 361,718 shares held of record by 7Wire Ventures LLCSeries Livongo D; (vi) 400,528 shares held of record by 7Wire Ventures LLCSeries Livongo E, collectively, the 7Wire Series; and (vii) 1,159,901 shares held of record by 7Wire Ventures Fund, L.P. for which 7Wire Management, LLC, or 7Wire Management, serves as the Manager. As a Manager of 7Wire Series and 7Wire Management, Mr. Shapiro shares voting and dispositive power with respect to the shares held of record by 7Wire Series and 7Wire LP. |
(2) | Based on approximately 94,482,000 shares of the Issuers common stock outstanding as of October 31, 2019, as reported in the Issuers Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2019, filed with the Securities and Exchange Commission on November 8, 2019. |
CUSIP No. 539183103 | Page 10 |
1 | NAME OF REPORTING PERSON:
Robert Garber | |||||
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):
| ||||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): (a) ☐ (b) ☐
| |||||
3 | SEC USE ONLY:
| |||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION:
United States |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5 | SOLE VOTING POWER
0 | ||||
6 | SHARED VOTING POWER
5,581,265(1) | |||||
7 | SOLE DISPOSITIVE POWER
0 | |||||
8 | SHARED DISPOSITIVE POWER
5,581,265(1) |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
5,581,265(1) | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):
☐ | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):
5.9%(2) | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
IN |
(1) | Consists of (i) 3,373,987 shares held of record by 7Wire Ventures LLC-Series EosHealth; (ii) 285,131 shares held of record by 7Wire Ventures LLCSeries Livongo C; (iii) 361,718 shares held of record by 7Wire Ventures LLCSeries Livongo D; (iv) 400,528 shares held of record by 7Wire Ventures LLCSeries Livongo E, collectively, the 7Wire Series; and (v) 1,159,901 shares held of record by 7Wire Ventures Fund, L.P. for which 7Wire Management, LLC, or 7Wire Management, serves as the Manager. As a Manager of 7Wire Series and 7Wire Management, Mr. Garber shares voting and dispositive power with respect to the shares held of record by 7Wire Series and 7Wire LP. |
(2) | Based on approximately 94,482,000 shares of the Issuers common stock outstanding as of October 31, 2019, as reported in the Issuers Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2019, filed with the Securities and Exchange Commission on November 8, 2019. |
Item 1 | |
(a) Name of Issuer:
Livongo Health, Inc.
(b) Address of Issuers Principal Executive Offices:
150 West Evelyn Avenue, Suite 150
Mountain View, California 94041
Item 2 | |
(a) Names of Persons Filing:
Each of the following is a reporting person (Reporting Person):
7Wire Ventures LLCSeries EosHealth
7Wire Ventures LLCSeries Livongo C
7Wire Ventures LLCSeries Livongo D
7Wire Ventures LLCSeries Livongo E
7Wire Ventures Fund, L.P.
7Wire Management, LLC
Glen Tullman
Lee Shapiro
Robert Garber
(b) Address or principal business office or, if none, residence:
The address for the principal business office of the Reporting Persons is:
444 N Michigan Avenue
Chicago, Illinois 60611
(c) Citizenship:
Reference is made to the response to item 4 on each of pages 2 - 10 of this Schedule 13G (this Schedule), which responses are incorporated herein by reference.
(d) Title and Class of Securities:
Common Stock, par value $0.001 per share.
(e) CUSIP No.:
539183103
Item 3. If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a:
Not applicable.
Item 4. Ownership
Reference is hereby made to the responses to items 5-9 and 11 of pages 2 - 10 of this Schedule, which responses are incorporated herein by reference.
Item 5. Ownership of Five Percent or Less of a Class
Not applicable.
Item 6. Ownership of More than 5 Percent on Behalf of Another Person
Not applicable.
Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not applicable.
Item 8. Identification and Classification of Members of the Group
Not applicable.
Item 9. Notice of Dissolution of Group
Not applicable.
Item 10. Certifications
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: February 14, 2020
7WIRE VENTURES LLC - SERIES EOSHEALTH | ||
By: | /s/ Robert Garber | |
Name: | Robert Garber | |
Its: | Manager | |
7WIRE VENTURES LLC SERIES LIVONGO C | ||
By: | /s/ Robert Garber | |
Name: | Robert Garber | |
Its: | Manager | |
7WIRE VENTURES LLC SERIES LIVONGO D | ||
By: | /s/ Robert Garber | |
Name: | Robert Garber | |
Its: | Manager | |
7WIRE VENTURES LLC SERIES LIVONGO E | ||
By: | /s/ Robert Garber | |
Name: | Robert Garber | |
Its: | Manager | |
7WIRE VENTURES FUND, L.P. | ||
By: | 7WIRE MANAGEMENT, LLC | |
Its: | Manager | |
By: | /s/ Robert Garber | |
Name: | Robert Garber | |
Title: | Manager | |
7WIRE MANAGEMENT, LLC | ||
By: | /s/ Robert Garber | |
Name: | Robert Garber | |
Title: | Manager | |
/s/ Glen Tullman | ||
Glen Tullman | ||
/s/ Lee Shapiro | ||
Lee Shapiro | ||
/s/ Robert Garber | ||
Robert Garber |
Exhibit Index
Exhibit 99.1 | Agreement of Joint Filing by and among 7Wire Ventures LLC-Series EosHealth, 7Wire Ventures LLCSeries Livongo C, 7Wire Ventures LLCSeries Livongo D, 7Wire Ventures LLCSeries Livongo E, 7Wire Ventures Fund, L.P., 7Wire Management, LLC, Glen Tullman, Lee Shapiro and Robert Garber dated February 14, 2020 |